Results 241 to 250 of about 215,233 (317)
Serotonergic modulators in Alzheimer's disease: a hope in the hopeless condition
Alzheimer disease (AD) is the main cause of dementia worldwide. AD is a progressive brain neurodegenerative disease due to genetic and environmental factors that induce a progressive accumulation of intracellular hyperphosphorylated tau protein and extracellular amyloid protein (Aβ).
Ali I. Al-Gareeb+5 more
wiley +1 more source
Safety Net Hospitals and the Quality of Surgical Care. [PDF]
Mehra S+8 more
europepmc +1 more source
Sacral erector spinae plane block for chronic pain: Fascial plane block or more? [PDF]
Sanapo A+3 more
europepmc +1 more source
ABSTRACT Background Diabetes mellitus (DM) is a well‐known risk factor for cardiovascular diseases, including coronary artery diseases (CAD). Complex percutaneous coronary intervention (PCI) such as PCI for bifurcation lesions often yields poor outcomes, especially in DM patients.
Subin Lim+31 more
wiley +1 more source
One-session endoscopic ultrasound-guided cholecystoduodenostomy for treatment of a high-surgical risk patient with symptomatic cholelithiasis of remnant gallbladder. [PDF]
Mondragón OVH+2 more
europepmc +1 more source
ABSTRACT Background Intravascular lithotripsy (IVL) is increasingly used to treat coronary artery calcification (CAC). This study aimed to identify clinical and procedural factors associated with IVL treatment success. Methods This retrospective analysis included 454 patients (73 ± 9 years, 75% male) treated with IVL from the multicenter BENELUX‐IVL ...
Martijn J. H. van Oort+12 more
wiley +1 more source
Diagnostic performances of Claude 3 Opus and Claude 3.5 Sonnet from patient history and key images in Radiology's "Diagnosis Please" cases. [PDF]
Kurokawa R+8 more
europepmc +1 more source
ABSTRACT Background There is limited evidence on the safety and efficacy of biodegradable‐polymer sirolimus‐eluting ultra‐thin stent (BP‐SES) in patients at high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI). Aims This study aims to evaluate the clinical outcomes of HBR patients treated with BP‐SES and ≤ 30‐day dual ...
Andrea Erriquez+9 more
wiley +1 more source